0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Special Feature |

Pathological Case of the Month FREE

[+] Author Affiliations

Section Editor: Enid Gilbert-barness, MD

More Author Information
Arch Pediatr Adolesc Med. 2001;155(12):1384. doi:10.1001/archpedi.155.12.1383.
Text Size: A A A
Published online

Figure 1. Marked crescent formation of polymorphonuclear leukocytes associated with generalized edema and fibrotic expansions (hematoxylin-eosin, original magnification × 20).

Figure 2. Inflammatory infiltration of polymorphonclear leukocytes (hematoxylin-eosin, original magnification × 40).

The association of rapidly progressive glomerulonephritis and pulmonary hemorrhage is classically known as Goodpasture syndrome (GPS). In the presence of autoantibodies directed against glomerular and alveolar basement membranes, it is called Goodpasture disease (GPD) or anti-GBM disease. Goodpasture disease accounts for 20% to 40% of cases of GPS. The rest are caused by systemic vasculitis: most commonly by Wegener granulomatosis, microscopic polyarteritis, and systemic lupus erythematosus and less commonly by Churg-Strauss syndrome, Henoch-Schönlein purpura, Behçet disease, essential mixed cryoglobulinemia, rheumatoid vasculitis, and drugs such as penicillamine and hydralazine hydrochloride.1

Whereas some patients may manifest glomerulonephritis and pulmonary hemorrhage in isolation, others may have either severe pulmonary and renal involvement or proteinuria and hematuria along with normal renal and pulmonary functions.13 The presence of pulmonary hemorrhage is closely related to that of pulmonary irritants, especially cigarette smoking as in our patient.2,46 Pulmonary hemorrhage is extremely rare in nonsmokers.1

The most common laboratory abnormality in GPD is a positive result for anti-GBM antibodies in 90% of patients. The kidney biopsy finding of crescent formation may involve 80% to 100% of glomeruli. Diffuse linear immunoglobulin G deposition is seen along the GBM on an immunofluorescent examination.1,2,4 The biopsy findings and the presence of anti-GBM antibodies in our patient were consistent with GPD.

Rapidly progressive glomerulonephritis and such factors as systemic lupus erythematosus, polyarteritis nodosa, Henoch-Schönlein purpura, hypersensitivity angiitis, mixed connective tissue disease, Wegener granulomatosis, and a drug reaction that may cause pulmonary-renal syndrome should be considered in the differential diagnosis.1 The clinical and laboratory findings in our patient were inconsistent with these disorders.

Most patients with GPS progress rapidly to end-stage renal disease. Increased creatinine levels, oligoanuria, and the severity of renal lesions indicate a poor prognosis.4

New therapeutic approaches such as plasmapheresis and treatment with cyclosporine, cyclophosphamide, and prednisolone may be effective in 80% of patients.1,7 However, patients with end-stage renal failure and those who require dialysis rarely improve.1,2

Accepted for publication May 23, 2000.

Corresponding author and reprints: Ahmet Özel, MD, Melikşah Mh, Müstehak S, Akyurt Sitesi, C Blok, No. 4/10, Konya, Turkey.

Turner  ANRees  AJ Antiglomerular basement membrane disease. Davison  AMCameron  JSGrünfeld  JPKerr  DNSRitz  EWinearls  CGeds.Oxford Textbook of Nephrology. Oxford, England Oxford University Press1998;647- 666
Glassock  RJ Goodpasture's disease. Massry  SGGlassock  RJeds.Textbook of Nephrology. Baltimore, Md Williams and Wilkins1995;818- 823
Knoll  GRabin  EBums  BF Antiglomerular basement membrane antibody-mediated nephritis with normal pulmonary and renal function. Am J Nephrol. 1993;13494- 496
Link to Article
Herody  MBobrie  GGouvarin  CGrünfeld  JPNoel  LH Anti-GBM disease: predictive value of clinical, histological and serological data. Clin Nephrol. 1993;40249- 255
Bombassei  GJKaplan  AA The association between hydrocarbon exposure and antiglomerular basement membrane antibody-mediated disease (Goodpasture's syndrome). Am J Int Med. 1992;21141- 153
Link to Article
Garcia-Rostan y Perez  GMGarcia  BFPuras Gil  AM Pulmonary hemorrhage and antiglomerular basement membrane antibody-mediated glomerulonephritis after exposure to smoked cocaine (crack): a case report and review of the literature. Pathol Int. 1997;47692- 697
Link to Article
Querin  SSchürch  WBeaulieu  R Cyclosporin in Goodpasture's syndrome. Nephron. 1992;60355- 359
Link to Article

Tables

References

Turner  ANRees  AJ Antiglomerular basement membrane disease. Davison  AMCameron  JSGrünfeld  JPKerr  DNSRitz  EWinearls  CGeds.Oxford Textbook of Nephrology. Oxford, England Oxford University Press1998;647- 666
Glassock  RJ Goodpasture's disease. Massry  SGGlassock  RJeds.Textbook of Nephrology. Baltimore, Md Williams and Wilkins1995;818- 823
Knoll  GRabin  EBums  BF Antiglomerular basement membrane antibody-mediated nephritis with normal pulmonary and renal function. Am J Nephrol. 1993;13494- 496
Link to Article
Herody  MBobrie  GGouvarin  CGrünfeld  JPNoel  LH Anti-GBM disease: predictive value of clinical, histological and serological data. Clin Nephrol. 1993;40249- 255
Bombassei  GJKaplan  AA The association between hydrocarbon exposure and antiglomerular basement membrane antibody-mediated disease (Goodpasture's syndrome). Am J Int Med. 1992;21141- 153
Link to Article
Garcia-Rostan y Perez  GMGarcia  BFPuras Gil  AM Pulmonary hemorrhage and antiglomerular basement membrane antibody-mediated glomerulonephritis after exposure to smoked cocaine (crack): a case report and review of the literature. Pathol Int. 1997;47692- 697
Link to Article
Querin  SSchürch  WBeaulieu  R Cyclosporin in Goodpasture's syndrome. Nephron. 1992;60355- 359
Link to Article

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles